The third report concluded that all the intermediate policy results of the postal directive have been achieved in the reporting period (2005-2006): firstly, monopolies have been progressively reduced by either implementing the gradual market opening calendar enshrined in the postal directive (e.g. reduction of the reserved area to 50g on 1 January 2006) or by additionally opening important segments (such as direct mail) or fully opening the postal market (UK, SE, FI).

F. whereas, in periods of conflict, women encounter difficulties in gaining access to the reproductive care that they require, such as contraception, the treatment of sexually transmitted diseases, ante-natal care and the premature termination of pregnancy if the woman so desires, childbirth, postnatal care and treatment of menopause,

In the light of discussions in international fora, in particular Codex Alimentarius, in relation to the timing of the introduction of complementary foods into the diet of infants, it is appropriate to amend the current definitions of infant formulae and follow-on formulae and certain provisions on the labelling of follow-on formulae in Directive 91/321/EEC.

7. Infant formulae and follow-on formulae shall be labelled in such a way that it enables consumers to make a clear distinction between such products so as to avoid any risk of confusion between infant formulae and follow-on formulae.

All the intermediate policy results of the Postal Directive have been achieved to date: first, monopolies have been progressively reduced by either implementing the gradual market opening calendar enshrined in the Postal Directive (e.g. reduction of the reserved area to 50g on 1 January 2006) or by additionally opening important segments (such as direct mail) or fully opening the postal market (UK, SE, FI).

39. Stresses that, while hormone replacement therapy can alleviate the symptoms of the menopause, maintain constant bone hardness in women and reduce the risk of intestinal cancer, hormone replacement therapy significantly increases the risk of cardiovascular disease and breast cancer; calls on the Commission and Member States, therefore, to ensure that greater attention is drawn to the advantages and disadvantages of hormone replacement therapy as a treatment for problems associated with menstruation and the menopause and that alternatives to it are studied;